[Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group].

Abstract

High-dose chemotherapy with autologous stem cell transplantation remains the current standard of treatment for young patients with Hodgkin lymphoma in first relapse or in those who are refractory to first-line treatment. The most important prognostic factors in relapses are clinical stage IV, poor performance status, bulky mass, and less than partial… (More)

Topics

Cite this paper

@article{Mcikov2017TreatmentOR, title={[Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group].}, author={Heidi M{\'o}cikov{\'a} and Jana Markov{\'a} and Ľ Gah{\'e}rov{\'a} and Zachary Kral and Alice S{\'y}korov{\'a} and David Belada and V{\'a}clav Proch{\'a}zka and Lenka Martinkov{\'a} and Tom{\'a}{\vs} Papaj{\'i}k and Tomas Kozak}, journal={Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti}, year={2017}, volume={29 5}, pages={342-346} }